selected scholarly activity
-
conferences
- Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases. The long-term results of a randomized controlled trial (PET-CT Imaging prior to liver resection for colorectal adenocarcinoma metastases).. Journal of Clinical Oncology. 2018
- Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases: The long-term results of a randomized control trial.. Journal of Clinical Oncology. 2018
- Survival analysis of PETCAM: A multicenter randomized controlled trial of PET/CT versus no PET/CT for patients with resectable liver colorectal adenocarcinoma metastases.. Journal of Clinical Oncology. 390-390. 2012
- An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM). Journal of Clinical Oncology. 2011
-
journal articles
- Effect of PET‐CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long‐term results of a randomized controlled trial. Journal of Surgical Oncology. 121:1001-1006. 2020
- Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases. Journal of Surgical Oncology. 120:1420-1426. 2019
- Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases. Journal of the American Medical Association (JAMA). 311:1863-1863. 2014